Keyword Index

Browse for an article via relevant keywords across our entire electronic archive

Search results for: R
Results 91 - 100 of 365 shown below

  • ras effectors

    G Bocci, A Fioravanti, P Orlandi, N Bernardini, P Collecchi, M Del Tacca and R Danesi

    Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells

    advance online publication, 2005-07-19 00:00:00.000;

    doi:10.1038/sj.bjc.6602720

  • ras mutation

    M Weihrauch, M Benicke, G Lehnert, C Wittekind, R Wrbitzky and A Tannapfel

    Frequent k- ras -2 mutations and p16INK4Amethylation in hepatocellular carcinomas in workers exposed to vinyl chloride

    doi:10.1054/bjoc.2000.1675

  • ras oncogene

    B van Etten, T L M ten Hagen, M R de Vries, G Ambagtsheer, T Huet and A M M Eggermont

    Prerequisites for effective adenovirus mediated gene therapy of colorectal liver metastases in the rat using an intracellular neutralizing antibody fragment to p21-Ras

    doi:10.1038/sj.bjc.6600089

  • T Urban, S Ricci, C Danel, M Antoine, M Kambouchner, V Godard, R Lacave and J-F Bernaudin

    Detection of codon 12 K- ras mutations in non-neoplastic mucosa from bronchial carina in patients with lung adenocarcinomas

    doi:10.1054/bjoc.1999.0935

  • ras superfamily

    A Di Paolo, R Danesi, S Caputo, M Macchia, M Lastella, U Boggi, F Mosca, A Marchetti and M Del Tacca

    Inhibition of protein farnesylation enhances the chemotherapeutic efficacy of the novel geranylgeranyltransferase inhibitor BAL9611 in human colon cancer cells

    doi:10.1054/bjoc.2001.1820

  • rasoncogene

    P Keohavong, H H Mady, W M Gao, J M Siegfried, J D Luketich and M F Melhem

    Topographic analysis of K-rasmutations in histologically normal lung tissues and tumours of lung cancer patients

    doi:10.1054/bjoc.2001.1913

  • RASSF1A

    A Misawa, S Tanaka, S Yagyu, K Tsuchiya, T Iehara, T Sugimoto and H Hosoi

    RASSF1A hypermethylation in pretreatment serum DNA of neuroblastoma patients: a prognostic marker

    doi:10.1038/sj.bjc.6604887

  • RASSF2

    M Endoh, G Tamura, T Honda, N Homma, M Terashima, S Nishizuka and T Motoyama

    RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer

    advance online publication, 2005-11-01 00:00:00.000;

    doi:10.1038/sj.bjc.6602854

  • K Harada, S Hiraoka, J Kato, J Horii, H Fujita, K Sakaguchi and Y Shiratori

    Genetic and epigenetic alterations of Ras signalling pathway in colorectal neoplasia: analysis based on tumour clinicopathological features

    advance online publication, 2007-10-09 00:00:00.000;

    doi:10.1038/sj.bjc.6604014

  • Rat

    T L M ten Hagen, S Hoving, G Ambagtsheer, S T van Tiel and A M M Eggermont

    Lack of efficacy of Doxil® in TNF-alpha-based isolated limb perfusion in sarcoma-bearing rats

    doi:10.1038/sj.bjc.6601688

  • C Wibom, F Pettersson, M Sjöström, R Henriksson, M Johansson and A T Bergenheim

    Protein expression in experimental malignant glioma varies over time and is altered by radiotherapy treatment

    advance online publication, 2006-05-30 00:00:00.000;

    doi:10.1038/sj.bjc.6603190

  • B M van der Kolk, B M de Man, T Wobbes and T Hendriks

    Is early post-operative treatment with 5-fluorouracil possible without affecting anastomotic strength in the intestine?

    doi:10.1038/sj.bjc.6690086

  • J van den Boogert, R van Hillegersberg and H van Dekken

    Timing of illumination is essential for effective and safe photodynamic therapy: a study in the normal rat oesophagus

    doi:10.1038/sj.bjc.6690132

  • C J Barnes and M Lee

    Determination of an optimal dosing regimen for aspirin chemoprevention of 1,2-dimethylhydrazine-induced colon tumours in rats

    doi:10.1038/sj.bjc.6690263

  • L-M Lu, H Shisa, J-i Tanuma and H Hiai

    Propylnitrosourea-induced T-lymphomas in LEXF RI strains of rats: genetic analysis

    doi:10.1038/sj.bjc.6690432

  • S Kergozien, J-G Delcros, H Jouan and J-P Moulinoux

    Induction of Fos protein expression in spinal cord neurons of tumour-bearing rats

    doi:10.1038/sj.bjc.6690554

  • N J Panaro, N C Popescu, S R Harris and U P Thorgeirsson

    Flavone acetic acid induces a G2/M cell cycle arrest in mammary carcinoma cells

    doi:10.1038/sj.bjc.6690619

  • R Hornung, M K Fehr, J Monti-Frayne, B J Tromberg, M W Berns and Y Tadir

    Minimally-invasive debulking of ovarian cancer in the rat pelvis by means of photodynamic therapy using the pegylated photosensitizer PEG-m-THPC

    doi:10.1038/sj.bjc.6690740

  • R J Mairs, C L Wideman, W J Angerson, T L Whateley, M S Reza, J R Reeves, L M Robertson, A Neshasteh-Riz, R Rampling, J Owens, D Allan and D I Graham

    Comparison of different methods of intracerebral administration of radioiododeoxyuridine for glioma therapy using a rat model

    doi:10.1054/bjoc.1999.0879

  • A H van der Veen, J H W de Wilt, A M M Eggermont, S T van Tiel, A L B Seynhaeve and T L M ten Hagen

    TNF- alpha augments intratumoural concentrations of doxorubicin in TNF- alpha -based isolated limb perfusion in rat sarcoma models and enhances anti-tumour effects

    doi:10.1054/bjoc.1999.1027

  • M Johansson, R Henriksson, A T Bergenheim and L-O D Koskinen

    Interleukin-2 and histamine in combination inhibit tumour growth and angiogenesis in malignant glioma

    doi:10.1054/bjoc.2000.1354

  • H Yokoyama, S Goto, C-L Chen, T-L Pan, K Kawano and S Kitano

    Major hepatic resection may suppress the growth of tumours remaining in the residual liver

    doi:10.1054/bjoc.2000.1379

  • rat aortic ring assay

    E Van Valckenborgh, H De Raeve, L Devy, S Blacher, C Munaut, A Noël, E Van Marck, I Van Riet, B Van Camp and K Vanderkerken

    Murine 5T multiple myeloma cells induce angiogenesis in vitro and in vivo

    doi:10.1038/sj.bjc.6600137

  • rat carcinosarcoma

    M Cemazar, I Wilson, V E Prise, K M Bell, S A Hill and G M Tozer

    The endothelin B (ETB) receptor agonist IRL 1620 is highly vasoconstrictive in two syngeneic rat tumour lines: potential for selective tumour blood flow modification

    advance online publication, 2005-06-21 00:00:00.000;

    doi:10.1038/sj.bjc.6602672